logo
Select company
Select metric
$ -61.99MConsolidated Income
VS
Market
17
Sector
33
Industry
16
History
61
$ 6.4Close
$ 5.77 - $ 16.81 52-Week Range
Ticker Information

Ticker

EOLS

Company Name

EVOLUS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

EVOLUS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EOLS - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -61.99M
3/31/2025$ -56.2M
12/31/2024$ -50.42M
9/30/2024$ -55.46M
6/30/2024$ -53.21M
3/31/2024$ -60M
12/31/2023$ -61.69M
9/30/2023$ -63.02M
6/30/2023$ -66.37M
3/31/2023$ -71.7M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EVOLUS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -66.83M.
  • Over the past 5 years, EVOLUS INC's average Cons. Inc. has been $ -79.37M.
  • The median Cons. Inc. for EVOLUS INC during this period was $ -66.6M
  • EVOLUS INC reached its highest Cons. Inc. over the past 5 years at $ -46.81M.
  • The lowest Cons. Inc. recorded by EVOLUS INC in the same timeframe $ -163.01M

EVOLUS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
ESPR : ESPERION THERAPEUTICS INC $ -104.02MSIGA : SIGA TECHNOLOGIES INC $ 82.18MORGO : ORGANOGENESIS HOLDINGS INC $ -8.23MACB : AURORA CANNABIS INC $ -17.1MFLGT : FULGENT GENETICS INC $ -52.04MDH : DEFINITIVE HEALTHCARE CORP $ -436.9MLFMD : LIFEMD INC $ -4.9MCGC : CANOPY GROWTH CORP $ -374.09MKROS : KEROS THERAPEUTICS INC $ 18.77MWEAV : WEAVE COMMUNICATIONS INC $ -30.13M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

EOLS - Consolidated Income, Last 5 years

$ -163.01M

Minimum

Dec 31, 2020

$ -46.81M

Maximum

Dec 31, 2021

$ -79.37M

Average

$ -66.6M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M